Blood eosinophil count is a factor to consider when initiating inhaled corticosteroids (ICS). According to the 2020 Report of the Global Initiative for Chronic Obstructive Lung Disease (GOLD), the initiation of ICS treatment in combination with 1 or 2 long-acting bronchodilators in patients with a blood eosinophil count from 100 to 300 cells/µl is _____.
Better luck next time
GOLD also recommends that clinicians consider the use of ICS in combination with 1 or 2 long-acting bronchodilators if patients have had 1 moderate exacerbation of COPD per year.
For more COPD content, visit the Resource Center.
Nice job!